← All trials
NCT04048577
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2019
- Primary completion
- Feb 1, 2020
- Completion date
- Mar 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Regina Berkovich MD, PhD Inc.Lead sponsor
- Cedars-Sinai Medical CenterCollaborator
- BiogenCollaborator
- Regina Berkovich MD, PhD Inc.Overall official - principal investigator
- Regina Berkovich MD, PhD Inc.Reponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.